Florence K. L. Tangka

Florence K. L. Tangka

Auto-generated profile, based on publicly available information

Florence K. L. Tangka

Centers for Disease Control and Prevention, Atlanta, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2010 in Cancer
Verified
Journal Article
Open access
PDF file
FTFlorence K. Tangka
Florence K. Tangka
JTJustin G. Trogdon
Justin G. Trogdon
LRLisa C. Richardson
Lisa C. Richardson
DHDavid Howard
David Howard
SSSusan A. Sabatino
Susan A. Sabatino
EFEric A. Finkelstein
Eric A. Finkelstein
BACKGROUND: There has not been a comprehensive analysis of how aggregate cancer costs have changed over time. The authors present 1) updated estimates of the prevalence and total cost of cancer for select payers and how these have changed over the past 2 decades; and 2) for each payer, the distribution of payments by type of service over time to assess whether there have been shifts in cancer treatment settings.METHODS: Pooled data from the 2001 through 2005 Medical Expenditure Panel Survey and the 1987 National Medical Care Expenditure Survey were used for the analysis. The authors used an econometric approach to estimate cancer‐attributable medical expenditures by payer and type of service.RESULTS: In 1987, the total medical cost of cancer (in 2007 US dollars) was $24.7 billion. Private payers financed the largest share of the total (42%), followed by Medicare (33%), out of pocket (17%), other public (7%), and Medicaid (1%). Between 1987 and the 2001 to 2005 period, the total medical cost of cancer increased to $48.1 billion. In 2001 to 2005, the shares of cancer costs were: private insurance (50%), Medicare (34%), out of pocket (8%), other public (5%), and Medicaid (3%). The share of total cancer costs that resulted from inpatient admissions fell from 64.4% in 1987 to 27.5% in 2001 to 2005.CONCLUSIONS: The authors identified 3 trends in the total costs of cancer: 1) the medical costs of cancer have nearly doubled; 2) cancer costs have shifted away from the inpatient setting; and 3) the share of these costs paid for by private insurance and Medicaid have increased. Cancer 2010. Published 2010 by American Cancer Society.

25 February 2016 in Preventing Chronic Disease
Verified
Journal Article
Open access
CMCarol Mansfield
Carol Mansfield
FTFlorence K. L. Tangka
Florence K. L. Tangka
DEDonatus U. Ekwueme
Donatus U. Ekwueme
JSJudith Lee Smith
Judith Lee Smith
GGGery P. Guy
Gery P. Guy
AHA. Brett Hauber
A. Brett Hauber
Stated-preference methods provide a systematic approach to quantitatively assess the relative preferences for features of cancer screening tests. We reviewed stated-preference studies for breast, cervical, and colorectal cancer screening to identify the types of attributes included, the use of questions to assess uptake, and whether gaps exist in these areas. The goal of our review is to inform research on the design and promotion of public health programs to increase cancer screening. Using the PubMed and EconLit databases, we identified studies published in English from January 1990 through July 2013 that measured preferences for breast, cervical, and colorectal cancer screening test attributes using conjoint analysis or a discrete-choice experiment. We extracted data on study characteristics and results. We categorized studies by whether attributes evaluated included screening test, health care delivery characteristics, or both. Twenty-two studies met the search criteria. Colorectal cancer was the most commonly studied cancer of the 3. Fifteen studies examined only screening test attributes (efficacy, process, test characteristics, and cost). Two studies included only health care delivery attributes (information provided, staff characteristics, waiting time, and distance to facility). Five studies examined both screening test and health care delivery attributes. Overall, cancer screening test attributes had a significant effect on a patient's selection of a cancer screening test, and health care delivery attributes had mixed effects on choice. A growing number of studies examine preferences for cancer screening tests. These studies consistently find that screening test attributes, such as efficacy, process, and cost, are significant determinants of choice. Fewer studies have examined the effect of health care delivery attributes on choice, and the results from these studies are mixed. There is a need for additional studies on the barriers to cancer screening uptake, including health care delivery attributes, and the effect of education materials on preferences.

1 November 2006 in Cancer Causes & Control
Verified
Journal Article
Open access
PDF file
FTFlorence K. L. Tangka
Florence K. L. Tangka
JDJoseph Dalaker
Joseph Dalaker
SCSajal K. Chattopadhyay
Sajal K. Chattopadhyay
JGJames G. Gardner
James G. Gardner
JRJanet Royalty
Janet Royalty
RCRalph J. Coates
Ralph J. Coates
Objective To examine the extent to which the National Breast and Cervical Cancer Early Detection Program (Program) has helped to meet the mammography screening needs of underserved women. Methods Low-income, uninsured women aged 40–64 are eligible for free mammography screening through the Program. We used data from the U.S. Census Bureau to estimate the number of women eligible for services. We obtained the number of women receiving Program-funded mammograms from the Program. We then calculated the percentage of eligible women who received mammograms through the Program. Results In 2002–2003, of all U.S. women aged 40–64, approximately 4 million (8.5%) had no health insurance and had a family income below 250% of the federal poverty level, meeting Program eligibility criteria. Of these women, 528,622 (13.2%) received a Program-funded mammogram. Rates varied substantially by race and ethnicity. The percentage of eligible women screened in each state ranged from about 2% to approximately 79%. Conclusions Although the Program provided screening services to over a half-million low-income, uninsured women for mammography, it served a small percentage of those eligible. Given that in 2003 more than 2.3 million uninsured, low-income, women aged 40–64 did not receive recommended mammograms from either the Program or other sources, there remains a substantial need for services for this historically underserved population.

18 March 2015 in Cancer Causes & Control
Verified
Journal Article
Open access
PDF file
FTFlorence K. L. Tangka
Florence K. L. Tangka
DHDavid H. Howard
David H. Howard
JRJanet Royalty
Janet Royalty
LDLucinda P. Dalzell
Lucinda P. Dalzell
JMJacqueline Miller
Jacqueline Miller
IHIngrid J. Hall
Ingrid J. Hall
The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides breast and cervical cancer screens to low-income, uninsured, and underinsured women. We describe the number and proportion of women eligible for cervical cancer screening services and the proportion of eligible women screened over the period 1997–2012.

1 September 2017 in Preventive Medicine
Verified
Journal Article
Closed access
FTFlorence K. Tangka
Florence K. Tangka
SSSujha Subramanian
Sujha Subramanian
LMLee Rivers Mobley
Lee Rivers Mobley
SHSonja Hoover
Sonja Hoover
JWJiantong Wang
Jiantong Wang
SSSimple D. Singh
Simple D. Singh

2 April 2010 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
FTFlorence K. L. Tangka
Florence K. L. Tangka
BOBrett O’hAra
Brett O’hAra
JGJames G. Gardner
James G. Gardner
JTJoanna Turner
Joanna Turner
JRJanet Royalty
Janet Royalty
RCRalph J. Coates
Ralph J. Coates